Canada Life’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,256
| Closed | -$128K | – | 2287 |
|
|
2023
Q1 | $128K | Sell |
12,256
-3,952
| -24% | -$120K | ﹤0.01% | 1944 |
|
|
2022
Q4 | $548K | Buy |
16,208
+210
| +1% | +$10.2K | ﹤0.01% | 1697 |
|
|
2022
Q3 | $765K | Buy |
15,998
+3,466
| +28% | +$206K | ﹤0.01% | 1579 |
|
|
2022
Q2 | $713K | Buy |
12,532
+1,912
| +18% | +$121K | ﹤0.01% | 1598 |
|
|
2022
Q1 | $880K | Hold |
10,620
| – | – | ﹤0.01% | 1560 |
|
|
2021
Q4 | $2.15M | Buy |
10,620
+4,858
| +84% | +$1.05M | ﹤0.01% | 1168 |
|
|
2021
Q3 | $1.56M | Buy |
5,762
+1,046
| +22% | +$252K | ﹤0.01% | 1319 |
|
|
2021
Q2 | $1.21M | Buy |
4,716
+12
| +0.3% | +$3.32K | ﹤0.01% | 1425 |
|
|
2021
Q1 | $1.41M | Sell |
4,704
-243
| -5% | -$75.6K | ﹤0.01% | 1347 |
|
|
2020
Q4 | $1.26M | Sell |
4,947
-728
| -13% | -$188K | ﹤0.01% | 1401 |
|
|
2020
Q3 | $1.41M | Sell |
5,675
-302
| -5% | -$95K | ﹤0.01% | 1238 |
|
|
2020
Q2 | $2.08M | Sell |
5,977
-108
| -2% | -$33.7K | ﹤0.01% | 1050 |
|
|
2020
Q1 | $1.63M | Buy |
6,085
+434
| +8% | +$134K | ﹤0.01% | 1053 |
|
|
2019
Q4 | $1.81M | Buy |
5,651
+1,145
| +25% | +$332K | ﹤0.01% | 1190 |
|
|
2019
Q3 | $1.23M | Sell |
4,506
-9
| -0.2% | -$3.3K | ﹤0.01% | 859 |
|
|
2019
Q2 | $2.41M | Sell |
4,515
-120
| -3% | -$60.2K | 0.01% | 1072 |
|
|
2019
Q1 | $2.33M | Sell |
4,635
-849
| -15% | -$503K | 0.01% | 959 |
|
|
2018
Q4 | $2.56M | Buy |
5,484
+59
| +1% | +$35.6K | 0.01% | 883 |
|
|
2018
Q3 | $4.96M | Buy |
5,425
+135
| +3% | +$115K | 0.01% | 700 |
|
|
2018
Q2 | $3.87M | Buy |
5,290
+2,463
| +87% | +$2.84M | 0.01% | 805 |
|
|
2018
Q1 | $4.51M | Sell |
2,827
-10,831
| -79% | -$14M | 0.01% | 734 |
|
|
2017
Q4 | $12.2M | Sell |
13,658
-547
| -4% | -$324K | 0.03% | 470 |
|
|
2017
Q3 | $5.04M | Sell |
14,205
-676
| -5% | -$211K | 0.01% | 691 |
|
|
2017
Q2 | $4.36M | Buy |
14,881
+618
| +4% | +$179K | 0.01% | 722 |
|
|
2017
Q1 | $5.02M | Buy |
14,263
+930
| +7% | +$209K | 0.01% | 691 |
|
|
2016
Q4 | $2.46M | Buy |
13,333
+1,088
| +9% | +$221K | 0.01% | 966 |
|
|
2016
Q3 | $3.15M | Buy |
12,245
+504
| +4% | +$130K | 0.01% | 822 |
|
|
2016
Q2 | $2.5M | Buy |
11,741
+10,768
| +1,107% | +$2.41M | 0.01% | 901 |
|
|
2016
Q1 | $200K | Buy |
973
+315
| +48% | +$60.5K | ﹤0.01% | 1317 |
|
|
2015
Q4 | $166K | Hold |
658
| – | – | ﹤0.01% | 1396 |
|
|
2015
Q3 | $108K | Hold |
658
| – | – | ﹤0.01% | 1648 |
|
|
2015
Q2 | $123K | Hold |
658
| – | – | ﹤0.01% | 1712 |
|
|
2015
Q1 | $108K | Hold |
658
| – | – | ﹤0.01% | 1751 |
|
|
2014
Q4 | $153K | Hold |
658
| – | – | ﹤0.01% | 1458 |
|
|
2014
Q3 | $120K | Hold |
658
| – | – | ﹤0.01% | 1545 |
|
|
2014
Q2 | $126K | Hold |
658
| – | – | ﹤0.01% | 1412 |
|
|
2014
Q1 | $119K | Buy |
658
+341
| +108% | +$67.5K | ﹤0.01% | 1351 |
|
|
2013
Q4 | $54K | Buy |
+317
| New | +$51.1K | ﹤0.01% | 1739 |
|
Other funds holding NKTR
DTC
MAM
SCM
Canada Life's NKTR Position: Q2 2023 in Review
Canada Life sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 12,256 shares — an estimated $128K sold.
Canada Life first reported a position in NKTR in Q4 2013 and held it in 38 quarters. The position peaked at $12.2M in Q4 2017. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Canada Life reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Canada Life sold 12,256 Nektar Therapeutics shares in Q2 2023, an estimated $128K.
- Canada Life first reported a position in Nektar Therapeutics in Q4 2013 and held it in 38 quarters.
- Canada Life's Nektar Therapeutics position peaked at $12.2M in Q4 2017.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.